 |
AY20895 |
DTP3 |
1809784-29-9 |
C26H35N7O5 |
525.6 |
VIEW DETAILS > |
 |
AB12569 |
1,4-Bis((E)-5-(3,4,5-trimethoxyphenyl)pent-4-en-1-yl)-1,4-diazepane |
191089-59-5 |
C33H48N2O6 |
568.7440199999999 |
VIEW DETAILS > |
 |
AI62470 |
Nifeviroc |
934740-33-7 |
C33H42N4O6 |
590.7098 |
VIEW DETAILS > |
 |
BA39456 |
6-((4-Chlorobenzyl)oxy)-3-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl)-3',5'-bis(trifluoromethyl)-[1,1'-biphenyl]-2-ol |
2289690-31-7 |
C26H16ClF9N2O2 |
594.8561 |
VIEW DETAILS > |
 |
BC80719 |
Carbamic acid, N-[(1R)-2-[1,2-dihydro-1-(methylsulfonyl)spiro[3H-indole-3,4′-piperidin]-1′-yl]-2-oxo-1-[(phenylmethoxy)methyl]ethyl]-, 1,1-dimethylethyl ester |
180465-66-1 |
C28H37N3O6S |
543.6749 |
VIEW DETAILS > |
 |
AF38575 |
2-(2-((5-bromo-4-dodecylthiophen-2-yl)methylene)-3-oxo-2,3-dihydro-1H-inden-1-ylidene)malononitrile |
2001613-84-7 |
C29H31BrN2OS |
535.5382 |
VIEW DETAILS > |
 |
AE67967 |
GSK-A1 |
1416334-69-4 |
C29H27FN6O4S |
574.6259 |
VIEW DETAILS > |
 |
BA38833 |
(2S,2'S)-2,2'-(Hexadecanedioylbis(azanediyl))dipentanedioicacid |
1255861-91-6 |
C26H44N2O10 |
544.635 |
VIEW DETAILS > |
 |
AY94909 |
N,N-BIS(TETRADECYL)-4-BROMOANILINE |
192937-53-4 |
C34H62BrN |
564.7668 |
VIEW DETAILS > |
 |
AJ18943 |
(2S,4R)-4-(Toluene-4-sulfonyloxy)-2-(toluene-4-sulfonyloxymethyl)-pyrrolidine-1-carboxylic acid tert-butyl ester |
61478-27-1 |
C24H31NO8S2 |
525.6348 |
VIEW DETAILS > |